mRNA technology could help treat heart attacks

Genetic technology similar to the method of preparing the Covid-19 vaccine of the Pfizer-BioNTech and Moderna consortium could help treat heart attack patients.

This is the result of a new groundbreaking study.

Using mRNA technology, the technology to prepare a vaccine against Covid-19, King's College London, UK has found the genetic codes responsible for creating proteins that stimulate the production of heart cells, opening a new way to control heart cells. first-line treatment for heart attack patients.

mRNA technology can assist in stimulating heart cell production.

Lead researcher Professor Mauro Giacca said that the number of heart muscle cells at the time of human birth is equal to the number at the time of death.

After a heart attack, the heart is unable to heal or repair itself. Therefore, the team's goal is to find a therapy that stimulates heart cells to self-replicate, multiply and regenerate this organ.

"We're using vaccine technology from Pfizer and Moderna to inject mRNA proteins into the heart, deliver them where the remaining cells are, and prompt the cells to self-reproduce. New cells will take their place. dead cells," explains Professor Giacca.

In addition, the researchers are excited about the possibility that it could limit the damage to the heart once a heart attack occurs. In theory, when the protein was injected by the time the ambulance arrived, the patient's severity could be reduced and the risk of death could be avoided.

It is expected that clinical trials on humans can begin in 2 years.

In the US alone, about 805,000 people have a heart attack each year and this number in the UK is 100,000.